◆英語タイトル:Fluxion Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012892
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Fluxion Biosciences Inc (Fluxion) is a provider of analytical and live cell analysis tools. The company’s products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range of circulating tumor cell and liquid biopsy applications. Fluxion’s sequencing assays solutions provide ultra-sensitivity mutation detection from CTCs and cell-free DNA. The company serves biotech and pharmaceutical companies, academic institutions and government research organizations. It markets its products through a network of distributors in the US, Australia, New Zealand, China, Spain, France, Germany, Austria, India, Japan, Singapore, the Netherlands, Denmark and Iceland, among others. Fluxion is headquartered in South San Francisco, California, the US.
Fluxion Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fluxion Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fluxion Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fluxion Biosciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Fluxion Biosciences Enters into Distribution Agreement with Harvard Bioscience 10
Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 11
Fluxion Biosciences Enters into Co-Development Agreement with Stanford University School of Medicine 12
Fluxion Biosciences Enters Into Co-Development Agreement With Stanford University School of Medicine 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore 15
Fluxion Biosciences Inc – Key Competitors 16
Fluxion Biosciences Inc – Key Employees 17
Fluxion Biosciences Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
Oct 27, 2016: Fluxion Biosciences Launches Spotlight 59 NGS Oncology Panel For Liquid Biopsies 19
Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis 20
Mar 28, 2016: Fluxion Launches BioFlux Extended Flow Module 21
03/22/2016: Fluxion Announced the Use of Its IonFlux Automated Patch Clamp System in the Discovery of Genentech GNE-0723, a Novel Drug Compound Suitable for In Vivo Characterization 22
02/17/2016: Fluxion Biosciences Launches New Range of Circulating Tumor Cell (CTC) Recovery Kits- First Launch of Commercial Kits Targeting EMT Cells 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Fluxion Biosciences Inc, Medical Equipment, Key Facts 2
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fluxion Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fluxion Biosciences Inc, Deals By Market, 2011 to YTD 2017 8
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fluxion Biosciences Enters into Distribution Agreement with Harvard Bioscience 10
Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 11
Fluxion Biosciences Enters into Co-Development Agreement with Stanford University School of Medicine 12
Fluxion Biosciences Enters Into Co-Development Agreement With Stanford University School of Medicine 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore 15
Fluxion Biosciences Inc, Key Competitors 16
Fluxion Biosciences Inc, Key Employees 17